Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Open in API
Filings indexed 394 across all filing types
Latest filing 2026-05-21 Capital/Financing Update
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
교환가액의조정 (제16회차)
Capital/Financing Update Classification · 82% confidence The document is a formal disclosure of an adjustment to the exchange (conversion) price and number of convertible bond shares for the company’s 16th tranche of exchangeable bonds. It details the before/after conversion price, reason (share price decline), adjustment methodology, application date, and related issuance reference. This is an update to the company’s financing instruments/capital structure rather than a full financial report or a board management change. Therefore it best fits the “Capital/Financing Update” category (CAP).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제29기) 2026년 01월 01일~2026년 03월 31일” and includes extensive business overview, segment sales, capital changes, and detailed financial and operational information for the quarter. It is clearly the full quarterly report for Q1 2026, not merely an announcement or summary. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
주요사항보고서(영업정지)
Regulatory Filings Classification · 95% confidence The document is a Korean 주요사항보고서 (Key Matters Report) filed with the Financial Services Commission and Korea Exchange detailing a major operational suspension (영업정지) of a business division. It is a mandatory regulatory disclosure, not an earnings release, financial report, or other specialized filing. Therefore it falls under the generic Regulatory Filings category.
2026-05-15 Korean
주권매매거래정지 (중요한 영업정지)
Regulatory Filings Classification · 85% confidence The document is a notice of temporary trading suspension (“주권매매거래정지”) for a KOSDAQ-listed common share, citing market regulations. It is a regulatory announcement rather than a full report or delisting notice. It does not fit other specific categories, so it is classified as a general regulatory filing (RNS).
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed voting outcomes for AGM agenda items (approval of financial statements, director appointments, remuneration limits, etc.). It clearly reports the official shareholder vote results from the annual general meeting. This corresponds to Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-31 Korean
대표이사변경
Board/Management Information Classification · 95% confidence The document is an official announcement detailing a change in the company’s 대표이사 (CEO), listing the outgoing and incoming representatives, board resolution date, and biographical details. This fits the definition of a Board/Management Information filing (announcement of changes in the company’s board or senior management).
2026-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.